RNF20 levels correlate with the expression of HIF1α and its target genes in lung cancer patients, and Hif1a silencing or inhibition of glucose uptake rescue the increased growth and invasion capacity induced by RNF20 deficiency, suggesting that these approaches may be valuable therapeutic strategies in tumors with decreased RNF20 activity. This evidence concerns the gene RNF20 and lung carcinoma.